Public Policy Letters, Statements, Legal Briefs, & Other Responses
-
ACMG Comments on FDA Plausible Mechanism Draft Guidance
-
ACMG Response to RFI on Gene Therapies Access for Rare Diseases
-
Sign-on Letter Supporting the Saving Access to Laboratory Services Act
-
ACMG Comment to NCD on Germline Editing and Impact on People with Disabilities
-
ACMG Letter to Michigan Medicaid on Coverage of Prenatal & Carrier Screening
-
ACMG Letter to Indiana Medicaid Supporting Coverage of Prenatal Screening and Testing
-
ACMG Letter of Support for the Expanded Genetic Screening Act
-
ACMG Letter to CMS Requesting Reconsideration of Payment Determination for a PALB2 CPT Code 81307
-
ACMG Comments to CMS Regarding CY 2020 CLFS Preliminary Payment Determinations
-
ACMG Comments to CMS Concerning CLFS Gapfill Preliminary Determinations for GS Codes 81425, 81426, and 81427